Literature DB >> 7531202

Repression of a malignant cell-substratum adhesion phenotype by inhibiting the production of the anti-adhesive proteoglycan, PG-M/versican.

M Yamagata1, K Kimata.   

Abstract

Malignantly transformed cells usually display a rosette-like morphology of substratum adhesions (called podosomes) and disorganized microfilaments, and are often associated with elevated production of chondroitin sulphate. We previously showed that many tissues and cells express alternatively spliced multiforms of the large chondroitin sulphate proteoglycan termed PG-M (versican is one of the short transcripts). Since PG-M/versican inhibits many types of cell-substratum adhesion and is found to be excluded from focal contacts of cultured fibroblasts, it is likely that this proteoglycan is generally involved in regulating cell-substratum adhesion. We report here that PG-M/versican is selectively excluded from podosomes of human osteosarcoma cells and that specific inhibition of its biosynthesis by an antisense method suppresses such a malignant cell-adhesive phenotype. The results support the idea that PG-M/versican acts as an anti-adhesive molecule and raise the possibility that PG-M/versican controls one type of cancer cell behaviour.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7531202     DOI: 10.1242/jcs.107.9.2581

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  23 in total

1.  Tumoral environment triggers transcript anomalies in established tumors: induction of altered gene expression and of aberrant, truncated and B2 repeat-containing gene transcripts.

Authors:  P Rottiers; M Desmedt; H Dooms; R Contreras; J Grooten
Journal:  Neoplasia       Date:  1999-12       Impact factor: 5.715

2.  Versican isoform V1 regulates proliferation and migration in high-grade gliomas.

Authors:  Julia Onken; Sylvia Moeckel; Petra Leukel; Verena Leidgens; Fusun Baumann; Ulrich Bogdahn; Arabel Vollmann-Zwerenz; Peter Hau
Journal:  J Neurooncol       Date:  2014-07-27       Impact factor: 4.130

Review 3.  Versican and the regulation of cell phenotype in disease.

Authors:  Thomas N Wight; Michael G Kinsella; Stephen P Evanko; Susan Potter-Perigo; Mervyn J Merrilees
Journal:  Biochim Biophys Acta       Date:  2014-01-05

4.  Expression of versican in relation to chondrogenesis-related extracellular matrix components in canine mammary tumors.

Authors:  I Erdélyi; A J A M van Asten; J E van Dijk; H Nederbragt
Journal:  Histochem Cell Biol       Date:  2005-09-29       Impact factor: 4.304

5.  Massive aggrecan and versican accumulation in thoracic aortic aneurysm and dissection.

Authors:  Frank S Cikach; Christopher D Koch; Timothy J Mead; Josephine Galatioto; Belinda B Willard; Kelly B Emerton; Matthew J Eagleton; Eugene H Blackstone; Francesco Ramirez; Eric E Roselli; Suneel S Apte
Journal:  JCI Insight       Date:  2018-03-08

6.  Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration.

Authors:  Stephen P Evanko; Susan Potter-Perigo; Paul L Bollyky; Gerald T Nepom; Thomas N Wight
Journal:  Matrix Biol       Date:  2011-11-20       Impact factor: 11.583

7.  Inhibition of experimental metastasis and cell adhesion of murine melanoma cells by chondroitin sulfate-derivatized lipid, a neoproteoglycan with anti-cell adhesion activity.

Authors:  K Karasawa; N Sugiura; Y Hori; S Suzuki; J Onaya; K Sakurai; K Kimata
Journal:  Clin Exp Metastasis       Date:  1997-03       Impact factor: 5.150

8.  Dentin matrix protein-1 isoforms promote differential cell attachment and migration.

Authors:  Zofia von Marschall; Larry W Fisher
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

9.  Reprint of: A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease.

Authors:  Mary Y Chang; Yoshinori Tanino; Veronika Vidova; Michael G Kinsella; Christina K Chan; Pamela Y Johnson; Thomas N Wight; Charles W Frevert
Journal:  Matrix Biol       Date:  2014-04-12       Impact factor: 11.583

10.  Alteration of chondroitin sulfate composition on proteoglycan produced by knock-in mouse embryonic fibroblasts whose versican lacks the A subdomain.

Authors:  Keittisak Suwan; Sonoko Hatano; Prachya Kongtawelert; Peraphan Pothacharoen; Hideto Watanabe
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.